Ilika plc with ticker (LON:IKA) now has a potential upside of 214.3% according to Berenberg Bank.
Berenberg Bank set a target price of 110 GBX for the company, which when compared to the Ilika plc share price of 35 GBX at opening today (07/02/2024) indicates a potential upside of 214.3%. Trading has ranged between 25 (52 week low) and 67 (52 week high) with an average of 230,309 shares exchanging hands daily. The market capitalisation at the time of writing is £54,687,608.
Ilika plc is a United Kingdom-based company. The Company is engaged in developing and commercializing its cutting-edge solid-state batteries. The Company develops and commercializes its thin-film Stereax miniature solid-state batteries for powering implantable medical devices and industrial wireless sensors (IIoT) in specialist environments, as well as progressing the development of its large-format Goliath cells for electric vehicles (EV) and cordless appliances. It has a secured lease of approximately 1,600 square meters property for Stereax manufacturing scale-up and installed over 340 square meters clean room facility. The Company is enabling solutions for applications, such as industrial Internet of things (IoT), MedTech, electric vehicles (EV) and consumer electronics. The Company has its operations in the United States of America, China and Israel.
Ilika plc 214.3% potential upside indicated by Berenberg Bank
- Written by: Charlotte Edwards
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika CEO Graeme Purdy explains how ORKA could accelerate Goliath's commercialisation through underwater defence applications while maintaining the company's long-term electric vehicle strategy.
Ilika has launched ORKA for pressure-tolerant deep-sea batteries aimed at autonomous underwater vehicles and defence applications.
ika has launched ORKA, a new brand for its pressure-tolerant batteries designed for autonomous underwater vehicles. The technology supports operations at depths of up to 6,000 metres and forms part of the company's strategy to commercialise its Goliath batteries in defence and other non-automotive markets.
Ilika will attend NANS 2027 in Las Vegas, engaging with the neuromodulation and medical technology sectors as it develops its Stereax solid-state batteries for medical devices.
Ilika is pursuing defence and e-bike applications to accelerate commercial opportunities for its Goliath solid-state batteries while continuing development for the electric vehicle market.
Ilika's Stereax miniature solid-state batteries will be represented by Cirtec Medical at MD&M Midwest in Minneapolis as the company continues to develop medical device applications.
